Market Cap 260.29M
Revenue (ttm) 128.26M
Net Income (ttm) 12.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 9.36%
Debt to Equity Ratio 2.39
Volume 275,900
Avg Vol 167,720
Day's Range N/A - N/A
Shares Out 37.03M
Stochastic %K 79%
Beta 0.80
Analysts Sell
Price Target $8.50

Latest News on LFCR

Lifecore Biomedical Announces Special Stockholder Meeting

Jan 17, 2025, 5:24 PM EST - 2 months ago

Lifecore Biomedical Announces Special Stockholder Meeting


Lifecore Biomedical: An Interesting CDMO Pure Play

Dec 1, 2024, 10:40 AM EST - 4 months ago

Lifecore Biomedical: An Interesting CDMO Pure Play


Lifecore Biomedical Hosts Virtual Investor Day

Nov 21, 2024, 4:17 PM EST - 4 months ago

Lifecore Biomedical Hosts Virtual Investor Day